Answer
No, empagliflozin’s glucose-lowering mechanism is independent of pancreatic beta-cell function and the insulin pathway, contributing to a low risk of hypoglycaemia.
Sources for this answer
- Empagliflozin 10 mg and 25 mg film-coated tablets (previously known as Jardiance)Boehringer Ingelheim Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 30Document updated
Sources checked